Status:
COMPLETED
Efficacy of PoNS in Reducing Symptoms of Multiple Sclerosis
Lead Sponsor:
Helius Medical Inc
Collaborating Sponsors:
McGill University
Conditions:
Multiple Sclerosis
Eligibility:
All Genders
28-62 years
Phase:
NA
Brief Summary
The purpose of this pilot study is to determine whether a program involving both in-lab and at-home training using cranial nerve stimulation (CN-NINM) delivered via the tongue can reduce symptoms of m...
Detailed Description
Fourteen MS patients, seven each in an active and a sham stimulation group are expected to participate. Participants will receive intensive physical therapy and working memory training for 14 weeks. ...
Eligibility Criteria
Inclusion
- Relapsing/remitting or secondary progressive MS with balance and gait problems;
- Recent EDSS score of 3.0 - 6.0;
- Provided informed consent and willing to participate
Exclusion
- Use of tobacco products;
- Oral health problems including abrasions, cuts, cold sores, piercings, or tissue inflammation in the oral cavity;
- Baseline EDSS \>6.
Key Trial Info
Start Date :
December 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2016
Estimated Enrollment :
14 Patients enrolled
Trial Details
Trial ID
NCT04496531
Start Date
December 1 2014
End Date
August 1 2016
Last Update
August 5 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.